Valneva (VALN)

• Market cap: $954M
• 1 day: 4.19%
• 5 days: 10.96%
• 1 month: 17.09%
• 3 months: 29.71%
• 6 months: 21.31%
• Year to date: 27.68%
• 1 year: 46.48%
• 5 years: -59.65%
• 10 years: -59.65%
• Sector: Healthcare
• Industry: Biotechnology

About: Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.

Employees: 713